LIN Feng  

  • Doctoral Supervisor, Associate Chief Physician
  • Department: Oncology
  • Research Area: Oncology
  • Research Interests: Medical therapy of tumor
  • Contact: linfeng_2014@163.com
  • Associate Chief Physician, Department of Oncology, Shanghai Sixth People's Hospital, 2007                                               
  • MD from Anhui Medical University, 1995
  • PhD from Suzhou Univercity
  • Director, Department of Oncology, Shanghai Eighth People's Hospital
  1. Tian Wang , Dexing Wang , Lian Zhang, Ping Yang, Jing Wang, Qi Liu, Fei Yan and Feng Lin. The TGFbeta-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.Journal of experimental & clinical cancer research : CR 2019;38:226.          
  2. Zhang L, Yang P, Wang J, Liu Q, Wang T, Wang Y, Lin F. MiR-22 regulated T cell differentiation and hepatocellular carcinoma growth by directly targeting Jarid2.American journal of cancer research. 2021;11(5):2159-2173.                
  3. Dexing Wang,Guowei Qian,Jin Wang,Tian Wang,Lian Zhang,Ping Yang,Feng Lin. Visfatin is involved in the cisplatin resistance of osteosarcoma cells via upregulation of Snail and Zeb1.Cancer biology & therapy 2019;20:999-1006.            
  4. Ping Yang,Lian Zhang,Tian Wang,Yaling Wang,Tu Zhiquan,Feng Lin. Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Actincacer Effect Against Drug-Resistant Osteosarcoma.OncoTargets and Therapy.2020:13 8055-8067. 
  5. Tian Wang, Feng Lin, Yujing Huang , Guowei Qian , Wenxi Yu2, Haiyan Hu2, Tong Ji, Lina Tang, Yang Yao. The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy.Cancer Management and Research 2022:14 2945–2952
  • 01/01/2018-12/31/2021
    Shanghai Xuhui District Medical Summit Discipline Construction Project,   ¥ 600,000, SHXH201710,Prevention and comprehensive diagnosis and treatment of bone metastasis cancer and its complications
    Role: Project leader
  • 01/01/2020-12/31/2024
    Shanghai Xuhui District Medical Research Project ,  ¥100,000,SHXH201709,The regulatory mechanism of klf8 transcription factor in the initiation of lung metastasis in osteosarcoma
    Role: Project leader